Investigators assessed whether rusfertide could reduce phlebotomy dependency in patients with polycythemia vera.
Pembrolizumab continues to demonstrate a disease-free and overall survival benefit for patients with clear cell renal ...
In patients with previously treated advanced/metastatic KRAS G12C NSCLC, divarasib improves survival compared with sotorasib ...
Niraparib plus dostarlimab with definitive cisplatin plus radiotherapy improves some outcomes in patients with locally ...
In patients with muscle-invasive bladder cancer (MIBC), treatment with neoadjuvant durvalumab and enfortumab vedotin, with or ...
In patients with extensive-stage small cell lung cancer, adding tarlatamab to durvalumab maintenance therapy significantly ...
Combined electronic nudges effectively facilitate serious illness conversations between patients with cancer and their ...
The intismeran/pembrolizumab combination significantly improved relapse-free and distant metastasis-free survival in advanced ...
(HealthDay News) — State health officials fighting measles outbreaks this spring asked the US Centers for Disease Control and Prevention (CDC) for help getting a faster test. The agency took 2 months ...
The conversion from accelerated to traditional approval updates the tumor mutational burden threshold from 10 to 13 mutations/megabase based on confirmatory KEYNOTE-158 data.
Nivolumab-ipilimumab prolongs OS compared to nivolumab alone or chemo in MSI-H or dMMR, unresectable or metastatic colorectal ...
Combining the novel, highly selective HDAC inhibitor HBI-8000 with nivolumab significantly improves PFS in unresectable ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results